Search

NILU har gjennomført måleprogram for konsentrasjoner i luft ved Franzefoss Gjenvinning AS sine anlegg ved Eide på Sotra og ved Husøya ved Kristiansund. Ved Eide ble det tatt prøver i luft og analysert for prioriterte miljøgifter som dekloraner, fenoler, ftalater, PFAS, benzotriazoler, organiske tinnforbindelser, samt VOC inkludert D6, ammoniakk (NH3), gassfase HCl og hydrogensulfid (H2S). For de prioriterte miljøgiftene var de fleste prøvene under deteksjonsgrensen. De høyeste verdiene ble observert ved Lokasjon 11 Vannrenseanlegget. Ved Husøya ble det tatt prøver i luft og analysert for VOC inkludert D6, ammoniakk (NH3) og gassfase HCl. Verdiene ved Husøya var lavere enn ved Eide. NILU has conducted a monitoring program for environmental toxics in air at Franzefoss Eide, Sotra (W. Norway) and Husøya, Kristiansund (NW Norway). At Eide, the samples were analyzed for dechlorane, phenols, phthalates, PFAS, benzotriazoles, organotin compounds, as well as VOCs including D6, ammonia (NH3), hydrogen chloride (HCl) and hydrogen sulphide (H2S). At Husøya the samples were analyzed for VOCs including D6, ammonia (NH3) and hydrogen chloride (HCl).

This report summarizes the findings of a screening study into the occurrence of selected benzothiazoles, siloxanes, pigments & PBT compounds in effluents, sewage sludge, surface water, sediments and biota.

The application of pharmaceuticals and personal care products is substantial in industrialized and high-income north-western European societies. Faroe Island, Iceland and Greenland are part of this modern society, although some areas are more suffused by technology and modern living than others. This also pertains to the standards of the local solutions for waste water treatment systems, but not so much to the health services. The present report summarises the results of screening analyses of pharmaceuticals and additives in personal care products in presumed hotspots in Faroe Islands, Iceland and Greenland. The study focuses on sewage lines from households and industry in general, and from hospitals. In all 38 pharmaceuticals or metabolites of pharmaceuticals and 7 personal care products were analysed.